Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Optimizing Prograf® Therapy in Renal Transplant Patients

ClinicalTrials.gov ID: NCT00297765

Public ClinicalTrials.gov record NCT00297765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 2:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OPTIMA (Optimizing Prograf® Therapy in Renal Transplant Patients)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to determine the optimal dose and blood level of Prograf® in long-term maintenance of kidney transplant patients.

Study identification

NCT ID
NCT00297765
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
323 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2002
Primary completion
Not listed
Completion
Feb 28, 2006
Last update posted
Aug 25, 2008

2003 – 2006

United States locations

U.S. sites
42
U.S. states
25
U.S. cities
37
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Little Rock Arkansas 72205
Not listed Los Angeles California 90057
Not listed Palo Alto California 94304
Not listed San Diego California 92123
Not listed San Francisco California 94115
Not listed Denver Colorado 80262
Not listed Washington D.C. District of Columbia 20037
Not listed Atlanta Georgia 30309
Not listed Augusta Georgia 30912
Not listed Honolulu Hawaii 96817
Not listed Peoria Illinois 61603
Not listed Indianapolis Indiana 46202
Not listed Shreveport Louisiana 71103
Not listed Portland Maine 04102
Not listed Boston Massachusetts 02114
Not listed Ann Arbor Michigan 48109
Not listed Minneapolis Minnesota 55455
Not listed Omaha Nebraska 68198
Not listed Livingston New Jersey 07039
Not listed West Orange New Jersey 07052
Not listed Buffalo New York 14203
Not listed Long Island City New York 11794
Not listed Mineola New York 11501
Not listed New York New York 10016
Not listed New York New York 10021
Not listed New York New York 10032
Not listed Greenville North Carolina 27834
Not listed Hershey Pennsylvania 17033
Not listed Philadelphia Pennsylvania 19102
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19107
Not listed Philadelphia Pennsylvania 19141
Not listed Charleston South Carolina 29425
Not listed Nashville Tennessee 37232
Not listed Dallas Texas 75204
Not listed Galveston Texas 77555
Not listed San Antonio Texas 78284
Not listed Salt Lake City Utah 84132
Not listed Richmond Virginia 23298
Not listed Seattle Washington 98104
Not listed Spokane Washington 99208

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00297765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2008 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00297765 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →